DNER and gastric cancer: While a few inhibitors possibly counteracting PRDM1-high stomach cancer were discovered, the most frequent ones were those for epigenetics (Figure 2A), with the targets of these epigenetic inhibitors all pointing to BET protein (Figure 2B).